Isomorphic Laboratories, an AI-driven startup owned by Google parent firm Alphabet, announced plans to foray into drug discovery and development by tapping into the technology of its sister company DeepMind. 

Talkatoo, creators of the easy-to-use, efficient and platform-agnostic dictation software for animal health professionals, announced the closing of a new, oversubscribed round of funding led by Klick Ventures.

Facebook Inc. removed over three dozen pages spreading misinformation about Covid-19 vaccines, after the White House called on social media firms to tighten controls on pandemic-related facts shared on their platforms.

Google’s Verily snapped up Raleigh, N.C.-based SignalPath and the company’s clinical trial management system that is expected to support its own clinical trial and evidence-based platform known as Baseline.

Klick Health and Lakeridge Health introduced a technologically advanced medication dosage calculator to help pharmacists and physicians determine the correct amount of vancomycin for treating life-threatening, antibiotic-resistant, bacterial infections.

By 2023, marketers will no longer have access to third-party cookies on Google Chrome. The move aligns with the policy of Apple Safari and Mozilla Firefox, which have already blocked third-party cookies and left Chrome representing 92 percent of the remaining cookies on the internet. Many pharmaceutical brands have not invested solely in a cookie-based approach over the years, so those marketers were able to pursue additional marketing tactics on endemic and Point of Care channels to engage physicians during campaigns.

New research from Klick Applied Sciences found that people using interactive voice technology for information on medications still get the most accurate results from Google Assistant. Management says the data are especially relevant as consumers have increasingly been turning to these platforms during the pandemic.

New research from Klick Applied Sciences found that people using interactive voice technology for information on medications still get the most accurate results from Google Assistant. The data are especially relevant as consumers have increasingly been turning to these platforms during the pandemic.

In an effort to boost drug discovery for the “toughest drug discovery problems” through the use of machine learning, precision medicines company Relay Therapeutics is acquiring Waltham, Mass.-based ZebiAI with an $85 million upfront payment.

Studies have concluded that chatbots have the potential in treating mental health issues and could be used as an effective tool for delivering cognitive behavioral therapy.